Conformis Inc
NASDAQ:CFMS
Intrinsic Value
ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. [ Read More ]
The intrinsic value of one CFMS stock under the Base Case scenario is 5.51 USD. Compared to the current market price of 2.26 USD, Conformis Inc is Undervalued by 59%.
Valuation Backtest
Conformis Inc
Run backtest to discover the historical profit from buying and selling CFMS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Conformis Inc
Current Assets | 54.6m |
Cash & Short-Term Investments | 26.2m |
Receivables | 7.8m |
Other Current Assets | 20.6m |
Non-Current Assets | 13.2m |
PP&E | 12.6m |
Other Non-Current Assets | 548k |
Current Liabilities | 10.8m |
Accounts Payable | 3.6m |
Accrued Liabilities | 6.6m |
Other Current Liabilities | 585k |
Non-Current Liabilities | 25m |
Long-Term Debt | 20.6m |
Other Non-Current Liabilities | 4.3m |
Earnings Waterfall
Conformis Inc
Revenue
|
57.1m
USD
|
Cost of Revenue
|
-38.1m
USD
|
Gross Profit
|
18.9m
USD
|
Operating Expenses
|
-59.5m
USD
|
Operating Income
|
-40.5m
USD
|
Other Expenses
|
-977k
USD
|
Net Income
|
-41.5m
USD
|
Free Cash Flow Analysis
Conformis Inc
CFMS Profitability Score
Profitability Due Diligence
Conformis Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
Score
Conformis Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
CFMS Solvency Score
Solvency Due Diligence
Conformis Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Conformis Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CFMS Price Targets Summary
Conformis Inc
According to Wall Street analysts, the average 1-year price target for CFMS is 2.27 USD .
Ownership
CFMS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
CFMS Price
Conformis Inc
Average Annual Return | -23.37% |
Standard Deviation of Annual Returns | 42.4% |
Max Drawdown | -99% |
Market Capitalization | 17.8m USD |
Shares Outstanding | 7 877 490 |
Percentage of Shares Shorted | 1.11% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. The company is headquartered in Billerica, Massachusetts and currently employs 310 full-time employees. The company went IPO on 2015-07-01. The firm is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's unique knee and hip anatomy. The Company’s products include iUni, iDuo, iTotal CR, iTotal PS, iTotal Identity, Identity Imprint and Conformis Cordera hip system. The Company’s iFit Image-to-Implant technology platform includes iFit Design, iFit Printing and iFit Just-in-Time Delivery. Its Identity Imprint knee system provides a data-informed knee implant system that provides a level of personalization through its patient-specific instruments (PSI) and proprietary algorithms for pre-surgical planning. Its Image-to-Implant Platinum Services program offering services in United States. The firm offers a line of the sterile, personalized knee and hip implants and single-use instruments delivered to hospitals.
Contact
IPO
Employees
Officers
The intrinsic value of one CFMS stock under the Base Case scenario is 5.51 USD.
Compared to the current market price of 2.26 USD, Conformis Inc is Undervalued by 59%.